WILMINGTON,Merrion Pharmaceuticals has received a US patent for a drug delivery system based on peptide compounds.

Merrion is focused on development of new approaches for oral delivery of drugs.

“This patent covers new peptide compounds which can be physically or chemically complexed with an active substance, either a drug or a biological, in order to improve delivery across biological membranes,” the company said in a statement.

According to Merrion, the system will improve the delivery of active drug ingredients to specific targets and provide an alternative to delivery by injection.

Merrion: www.merrionpharma.com